Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Robert Lyle

Concepts (109)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ductus Arteriosus, Patent
2
2019
34
0.320
Why?
DNA
1
2010
545
0.280
Why?
Intensive Care Units, Neonatal
2
2018
110
0.270
Why?
Asthma
1
2010
283
0.270
Why?
Infant, Premature
4
2019
308
0.220
Why?
Medicaid
2
2018
257
0.210
Why?
Disabled Children
2
2013
63
0.190
Why?
Infant, Newborn
7
2019
2744
0.180
Why?
Hospitalization
2
2017
653
0.170
Why?
Persistent Fetal Circulation Syndrome
1
2019
9
0.170
Why?
Chronic Disease
3
2011
563
0.160
Why?
Health Care Costs
2
2018
170
0.160
Why?
Infant, Low Birth Weight
1
2018
62
0.160
Why?
Child, Preschool
7
2018
3853
0.160
Why?
Continuity of Patient Care
1
2018
53
0.150
Why?
Clinical Protocols
1
2017
108
0.140
Why?
Immunologic Deficiency Syndromes
1
2016
20
0.140
Why?
Hypoglycemia
1
2016
48
0.140
Why?
Infant, Premature, Diseases
1
2017
94
0.130
Why?
DNA Copy Number Variations
2
2016
110
0.130
Why?
Child
8
2018
6824
0.130
Why?
Developmental Disabilities
1
2016
119
0.130
Why?
Hospitals, Pediatric
3
2013
239
0.120
Why?
Emergency Service, Hospital
1
2018
488
0.110
Why?
Comprehensive Health Care
1
2013
7
0.110
Why?
Infant
6
2018
3551
0.110
Why?
Blood Cells
1
2012
43
0.100
Why?
Genome, Human
1
2012
111
0.100
Why?
Child, Exceptional
1
2011
5
0.100
Why?
Cost Savings
1
2011
58
0.090
Why?
Parents
1
2013
312
0.090
Why?
Follow-Up Studies
2
2018
2179
0.090
Why?
Fetal Blood
1
2010
67
0.090
Why?
Longitudinal Studies
3
2018
673
0.090
Why?
Gene Expression Regulation, Developmental
1
2010
138
0.090
Why?
Genetic Association Studies
1
2010
116
0.090
Why?
Ambulatory Care
1
2011
222
0.080
Why?
Patient Care Team
1
2011
255
0.080
Why?
Humans
13
2022
49827
0.080
Why?
Outpatient Clinics, Hospital
1
2009
36
0.080
Why?
Time Factors
2
2018
2912
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2013
488
0.080
Why?
Genotype
1
2010
538
0.080
Why?
Child Health Services
1
2009
77
0.080
Why?
Home Care Services
1
2009
73
0.080
Why?
Female
8
2018
26329
0.080
Why?
Polymorphism, Single Nucleotide
1
2010
485
0.070
Why?
Male
7
2018
25093
0.070
Why?
DNA Methylation
1
2010
548
0.070
Why?
Cohort Studies
3
2018
1422
0.060
Why?
Patient Discharge
2
2018
322
0.060
Why?
Prospective Studies
1
2010
2344
0.060
Why?
Embryonic Stem Cells
1
2022
15
0.050
Why?
Cell Differentiation
2
2022
653
0.050
Why?
Age Factors
2
2018
1090
0.050
Why?
Adolescent
3
2018
6340
0.050
Why?
Acetylcysteine
1
2002
100
0.050
Why?
Peptide Hydrolases
1
2002
62
0.050
Why?
Phosphoproteins
1
2002
113
0.050
Why?
Proteasome Endopeptidase Complex
1
2002
114
0.050
Why?
Arkansas
3
2013
1967
0.050
Why?
Adipocytes
1
2002
121
0.050
Why?
Cell Survival
1
2022
598
0.050
Why?
Neurons
1
2022
459
0.040
Why?
Proteins
1
2002
341
0.040
Why?
Time
1
2018
25
0.040
Why?
Ibuprofen
1
2018
21
0.040
Why?
Indomethacin
1
2018
38
0.040
Why?
United States
3
2018
4838
0.040
Why?
Cyclooxygenase Inhibitors
1
2018
39
0.040
Why?
Birth Weight
1
2019
120
0.040
Why?
Infant, Newborn, Diseases
1
2016
57
0.030
Why?
Patient Readmission
1
2018
222
0.030
Why?
Incidence
1
2018
1003
0.030
Why?
Logistic Models
1
2018
891
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2016
169
0.030
Why?
Young Adult
2
2016
3936
0.030
Why?
Databases, Factual
1
2018
664
0.030
Why?
Length of Stay
1
2018
623
0.030
Why?
Genomics
1
2016
282
0.030
Why?
Blood Glucose
1
2016
432
0.030
Why?
Risk Assessment
1
2018
1262
0.030
Why?
Health Care Surveys
1
2013
174
0.030
Why?
Twins, Monozygotic
1
2012
17
0.030
Why?
Individuality
1
2012
30
0.030
Why?
Patient-Centered Care
1
2013
128
0.020
Why?
Myelodysplastic Syndromes
1
2012
80
0.020
Why?
Aged
2
2016
9272
0.020
Why?
Cerebral Palsy
1
2010
40
0.020
Why?
Cost-Benefit Analysis
1
2011
273
0.020
Why?
Bronchopulmonary Dysplasia
1
2010
70
0.020
Why?
Multivariate Analysis
1
2011
585
0.020
Why?
Middle Aged
2
2016
11997
0.020
Why?
Adult
2
2016
13160
0.020
Why?
Quality of Life
1
2013
833
0.020
Why?
Program Evaluation
1
2009
349
0.020
Why?
Rural Population
1
2011
535
0.020
Why?
Mutation
1
2012
1293
0.020
Why?
Retrospective Studies
1
2018
6117
0.020
Why?
Aged, 80 and over
1
2012
3125
0.020
Why?
Treatment Outcome
1
2013
5138
0.010
Why?
Leupeptins
1
2002
7
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
Why?
Cysteine Proteinase Inhibitors
1
2002
22
0.010
Why?
Calpain
1
2002
25
0.010
Why?
Kinetics
1
2002
626
0.010
Why?
Nuclear Proteins
1
2002
243
0.010
Why?
Cell Line
1
2002
1002
0.010
Why?
Animals
1
2002
13150
0.000
Why?
Lyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description